Cargando…
The Incidence of Hepatocellular Carcinoma Is not Increased in Individuals with Chronic Hepatitis C After Treatment with Interferon-free Regimens: an ERCHIVES Study
BACKGROUND: Sustained virologic response (SVR) after interferon-based treatment for chronic hepatitis C virus (HCV) infection has been strongly linked with decreased incidence of hepatocellular carcinoma (HCC). Surprisingly, several recent studies have reported higher rates of HCC in individuals tre...
Autores principales: | Li, Darrick K, Ren, Yanjie, Saikh, Obaid, Fierer, Daniel S, Re, Vincent Lo, Abou-Samra, Abdul-Badi, Chung, Raymond T, Butt, Adeel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631674/ http://dx.doi.org/10.1093/ofid/ofx162.099 |
Ejemplares similares
-
Is DAA Treatment Associated with HBV Reactivation? Results from ERCHIVES
por: Butt, Adeel, et al.
Publicado: (2017) -
930. HCV Treatment Is Associated With a Reduced Risk of Cardiovascular Disease Events: Results From ERCHIVES
por: Butt, Adeel Ajwad, et al.
Publicado: (2018) -
HCV Treatment Initiation in Patients with Chronic Kidney Disease: Results from ERCHIVES
por: Butt, Adeel, et al.
Publicado: (2017) -
Changes in circulating lipids level over time after acquiring HCV infection: results from ERCHIVES
por: Butt, Adeel A., et al.
Publicado: (2015) -
Effectiveness and Safety of Sofosbuvir/Ledipasvir and Paritaprevir/ritonavir/Ombitasvir + Dasabuvir in Patients with Chronic Kidney Diseases: Results from ERCHIVES
por: Butt, Adeel, et al.
Publicado: (2017)